Antibiotic treatment of <i>Stenotrophomonas maltophilia</i> bacteraemia: does trimethoprim/sulfamethoxazole dose affect clinical outcomes?
High-dose trimethoprim/sulfamethoxazole for S. maltophilia bacteraemia was not associated with improved outcomes while more frequent adverse drug events were observed. The sample size and retrospective design limit the study's conclusions. Future studies that address these limitations are needed to confirm the results.
Authors
- Chien-Liang Chen
- Hung-Sheng Shang
- L. Kristopher Siu (ORCID: https://orcid.org/0000-0002-9840-3638)
- Weiping Chen (ORCID: https://orcid.org/0000-0002-0459-0605)
- Ya-Sung Yang
- Jung-Chung Lin
- Ching-Mei Yu
- Ching-Hsun Wang
- Feng‐Yee Chang
Institutions
- Tri-Service General Hospital (TW)
- National Health Research Institutes (TW)
- Zuoying Armed Forces General Hospital (TW)
- Taoyuan Armed Forces General Hospital (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1093/jac/dkaf131
- Citations
- 4
- Primary Topic
- Infections and bacterial resistance
- Type
- article
- Field-Weighted Citation Impact
- 7.19
Funders
- Tri-Service General Hospital